Teva Pharmaceutical Industries Limited (BVMF:T1EV34)

Brazil flag Brazil · Delayed Price · Currency is BRL
68.73
-1.74 (-2.47%)
At close: Nov 27, 2025
38.15%
Market Cap 172.71B
Revenue (ttm) 89.41B
Net Income (ttm) 3.80B
Shares Out n/a
EPS (ttm) 3.29
PE Ratio 45.45
Forward PE 10.75
Dividend n/a
Ex-Dividend Date n/a
Volume 3
Average Volume 22
Open 72.26
Previous Close 70.47
Day's Range 68.73 - 72.26
52-Week Range 39.30 - 72.26
Beta 0.70
RSI 69.18
Earnings Date Jan 28, 2026

About BVMF:T1EV34

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com... [Read more]

Sector Healthcare
Founded 1901
Employees 35,686
Stock Exchange Brazil Stock Exchange
Ticker Symbol T1EV34
Full Company Profile

Financial Performance

In 2024, BVMF:T1EV34's revenue was $16.54 billion, an increase of 4.40% compared to the previous year's $15.85 billion. Losses were -$1.64 billion, 193.2% more than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.